New approaches for imaging tumour responses to treatment

被引:350
作者
Brindle, Kevin [1 ,2 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 ORE, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1038/nrc2289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumour responses to treatment are still largely assessed from imaging measurements of reductions in tumour size. However, this can take several weeks to become manifest and in some cases may not occur at all, despite a positive response to treatment. There has been considerable interest, therefore, in non-invasive techniques for imaging tissue function that can give early evidence of response. These can be used in clinical trials of new drugs to give an early indication of drug efficacy, and subsequently in the clinic to select the most effective therapy at an early stage of treatment.
引用
收藏
页码:94 / 107
页数:14
相关论文
共 143 条
[81]   Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers [J].
Ljungkvist, Anna S. E. ;
Bussink, Johan ;
Kaanders, Johannes H. A. M. ;
van der Kogel, Albert J. .
RADIATION RESEARCH, 2007, 167 (02) :127-145
[82]   Molecular imaging in living subjects: seeing fundamental biological processes in a new light [J].
Massoud, TF ;
Gambhir, SS .
GENES & DEVELOPMENT, 2003, 17 (05) :545-580
[83]   Imaging of angiogenesis: from microscope to clinic [J].
McDonald, DM ;
Choyke, PL .
NATURE MEDICINE, 2003, 9 (06) :713-725
[84]   Neoadjuvant chemotherapy of locally advanced breast cancer:: Predicting response with in vivo 1H MR spectroscopy -: A pilot study [J].
Meisamy, S ;
Bolan, PJ ;
Baker, EH ;
Bliss, RL ;
Gulbahce, E ;
Everson, LI ;
Nelson, MT ;
Emory, TH ;
Tuttle, TM ;
Yee, D ;
Garwood, M .
RADIOLOGY, 2004, 233 (02) :424-431
[85]   HETEROGENEITY IN THE DEVELOPMENT OF APOPTOSIS IN IRRADIATED MURINE TUMORS OF DIFFERENT HISTOLOGIES [J].
MEYN, RE ;
STEPHENS, LC ;
ANG, KK ;
HUNTER, NR ;
BROCK, WA ;
MILAS, L ;
PETERS, LJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 1993, 64 (05) :583-591
[86]   Measuring response in a post-RECIST world: from black and white to shades of grey [J].
Michaelis, LC ;
Ratain, MJ .
NATURE REVIEWS CANCER, 2006, 6 (05) :409-414
[87]   Imaging angiogenesis: Applications and potential for drug development [J].
Miller, JC ;
Pien, HH ;
Sahani, D ;
Sorensen, AG ;
Thrall, JH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (03) :172-187
[88]   Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response [J].
Moffat, BA ;
Chenevert, TL ;
Lawrence, TS ;
Meyer, CR ;
Johnson, TD ;
Dong, Q ;
Tsien, C ;
Mukherji, S ;
Quint, DJ ;
Gebarski, SS ;
Robertson, PL ;
Junck, LR ;
Rehemtulla, A ;
Ross, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (15) :5524-5529
[89]   Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases:: Results from two phase I studies [J].
Morgan, B ;
Thomas, AL ;
Drevs, J ;
Hennig, J ;
Buchert, M ;
Jivan, A ;
Horsfield, MA ;
Mross, K ;
Ball, HA ;
Lee, L ;
Mietlowski, W ;
Fuxius, S ;
Unger, C ;
O'Byrne, K ;
Henry, A ;
Cherryman, GR ;
Laurent, D ;
Dugan, M ;
Marmé, D ;
Steward, WP .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3955-3964
[90]   A paramagnetic nanoprobe to detect tumor cell death using magnetic resonance imaging [J].
Neves, Andre A. ;
Krishnan, Anant S. ;
Kettunen, Mikko I. ;
Hu, De-En ;
de Backer, Maaike M. ;
Davletov, Bazbek ;
Brindle, Kevin M. .
NANO LETTERS, 2007, 7 (05) :1419-1423